Title : Co-inhibition of SMAD and MAPK signaling enhances 124I uptake in BRAF-mutant thyroid cancers.

Pub. Date : 2021 May 18

PMID : 33890869






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Treatment with follistatin, a potent inhibitor of activin, or vactosertib, which inhibits both TGFbetaR1 and the activin type I receptor ALK4, induced a profound inhibition of pSMAD in BrafV600E-PTCs. vactosertib activin A receptor, type 1B Mus musculus